Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
United States
Factor viii inhibitor bypassing activity

FDA 1979

Factor viii inhibitor bypassing activity

Autoplex, Feiba Nf, Feiba Vh

1000IU For InjectionUnited StatesNot marketedAuthorised 21 Dec 1979

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

FeibaItaly · Polvere e solvente per soluzione iniettabile · Baxalta Innovations GMBHSame form
FEIBA 100 E/ml, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Poeder en oplosmiddel voor oplossing voor infusie · Baxalta Innovations GmbHSame form
Feiba 1000 USingapore · 50 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form
Feiba 500 USingapore · 25 u/ml · injection, powder, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.Same form
Feiba NFCanada · 3250 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame substance
Feiba NFCanada · 1300 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INCSame substance
Feiba NF

More with the same substance on this register

Autoplex, Feiba Nf, Feiba VhFactor viii inhibitor bypassing activity · 500U · For InjectionUnited States
Autoplex, Feiba Nf, Feiba VhFactor viii inhibitor bypassing activity · 1000U · For InjectionUnited States

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Canada · 650 UNIT / VIAL · Kit, Powder For Solution · Takeda Canada INC

Same substance

🇭🇷Feiba 100 U/ml prašak i otapalo za otopinu za infuzijuCroatia · Prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame substance

🇭🇷octaplasLG 45-70 mg/ml otopina za infuzijuCroatia · otopina za infuziju · Octapharma (IP) SPRL, Allee De La Recherche 65, Anderlecht, BelgijaSame substance

🇭🇷Feiba 50 U/ml prašak i otapalo za otopinu za infuzijuCroatia · prašak i otapalo za otopinu za infuziju · Baxalta Innovations GmbH, Industriestrasse 67, Beč, AustrijaSame substance

🇷🇴FEIBA 25 U/mlRomania · 25U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBHSame substance

🇷🇴FEIBA 50 U/mlRomania · 50U/ml · pulb+solv. pt. sol. perf. · Baxalta Innovations GMBHSame substance

🇷🇸Feiba NFSerbia · 500j./20mL · prašak i rastvarač za rastvor za infuziju · Takeda DOOSame substance

🇸🇦Feiba 50U Powder&SolventSaudi Arabia · Baxter AGSame substance

🇸🇦Feiba 50U Powder&SolventSaudi Arabia · Takeda Manufacturing Austria AGSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Factor viii inhibitor bypassing activity
Strength: 1000IU
Dosage form: For Injection
Route: Intravenous
Register: United States (FDA)
Status: Not marketed
Status in the register: Licensed / Disc
Authorised: 21 Dec 1979
Registration: BLA 101447
Marketing authorisation holder: Takeda Pharmaceuticals U.S.A., Inc.
Procedure: 351(a)
Supply: Disc

FDAAutoplex, Feiba Nf, Feiba VhFactor viii inhibitor bypassing activity · 2500U · For Injection🇺🇸United States

FDAAutoplex, Feiba Nf, Feiba VhFactor viii inhibitor bypassing activity · 500IU · For Injection🇺🇸United States